iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged)
XFH.TO News Today: Stay Updated with the Latest iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged) News in Real Time
Find XFH.TO news now at Meyka AI. Stay informed with the latest iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged) stocks updates, including price news, market analysis, and expert insights.
Kevin Warsh Fed Hearing April 23: Trump’s Nominee Defends Independence
Kevin Warsh Fed hearing April 23: Trump’s nominee defends finances and independence. Democrats press rate-cut demands. Full takeaways.
CMOC Group Limited 3993.HK Earnings Alert: HK$19.31 Stock Ahead of April 24 Results
CMOC Group Limited (3993.HK) trades at HK$19.31 ahead of April 24 earnings announcement. Meyka AI rates the stock B+ with neutral outlook.
MSCI Inc. (MSCI) Earnings Beat: Q2 2026 Results Exceed Expectations
MSCI Inc. beat Q2 2026 earnings estimates with $4.55 EPS and $850.8M revenue, up 2.48% and 1.53% respectively. Stock up 1.78%.
F-15EX Eagle II April 23: Air Force Doubles Fleet Plan
Air Force doubles F-15EX Eagle II fleet to 267 jets amid Trump military surge. Boeing fighter jet procurement surges on April 23, 2026.
ASMIY: ASM International Beats Earnings by 20% on Strong Demand
ASM International (ASMIY) beat Q1 2026 EPS estimates by 20.29% with $5.87 actual vs $4.88 expected. Revenue topped forecasts at $1.01B.
RFR.CN Stock Holds C$0.02 as Earnings Loom April 24
RFR.CN stock trades at C$0.02 with earnings announcement April 24. Meyka AI rates the gold explorer with a B grade. Market cap C$7.97M.
PMC.AX Stock Flat at A$1.765 in Pre-Market, April 23
PMC.AX stock holds steady at A$1.765 in pre-market trading. Platinum Capital Limited shows neutral momentum with 730K volume on ASX.
COH.AX stock plunges 40.7% as Cochlear cuts profit guidance
COH.AX stock crashes 40.7% to A$99.58 after Cochlear Limited slashes earnings guidance. Healthcare sector weakness continues on ASX.
CNBX Stock Plunges 25% on Apr 22 as Biotech Faces Headwinds
CNBX stock drops 25% to $0.0003 on heavy volume of 238M shares. Meyka AI rates the cannabinoid biotech with a C grade.